Matrix interference in ligand-binding assays: challenge or solution?
Matrix effect in ligand-binding assay: the importance of evaluating emerging technologies
Orthogonal tools to help determine the required selectivity of ligand-binding assays in drug development
Are matrix effects the Achilles heel in the bioanalysis of biotherapeutics by ligand-binding assays?
Researchers develop simple and efficient test for diagnosis of diarrheal disease
Monitoring drug levels in real-time
Collaboration for analysis of Alzheimer's disease biomarker assays announced
Device holds promise for rapid pancreatic cancer diagnosis
Is the complex mechanism behind Parkinson's disease closer to being solved?
Challenges in selectivity, specificity and quantitation range of ligand-binding assays: case studies using a microfluidics platform
Addressing matrix effects in ligand-binding assays through the use of new reagents and technology
An ultra-sensitive clinical biomarker assay: quantitation of thymus and activation-regulated chemokine in human plasma
Evaluating the impact of matrix effects on biomarker assay sensitivity
Resolution of matrix interference: quantitative and quasi-quantitative ligand-binding assays case studies
Strategic approaches for assessment and minimization of matrix effect in ligand-binding assays
Measuring biotherapeutics with endogenous counterparts and pre-existing antibodies: an interferon case study
Due diligence in the characterization of matrix effects in a total IL-13 Singulex™ method
Protein-based matrix interferences in ligand-binding assays